Zhejiang Medicine Co Ltd: A Snapshot of Current Performance and Market Position
Zhejiang Medicine Co., Ltd., a prominent player in the health care sector, continues to make significant strides in the pharmaceutical industry. Based in Shaoxing, China, the company specializes in the manufacturing and marketing of chemical medicines and preparations. Its product range includes antibiotics, vitamins, and other pharmaceuticals, with operations extending into food manufacturing through its subsidiaries.
As of July 28, 2025, Zhejiang Medicine Co. Ltd. reported a close price of 15.46 CNH on the Shanghai Stock Exchange, where it is primarily listed. The company’s market capitalization stands at 14.6 billion CNH, reflecting its substantial presence in the industry. Over the past year, the stock has experienced fluctuations, reaching a 52-week high of 19.4 CNH on November 6, 2024, and a low of 11.6 CNH on April 8, 2025.
The company’s financial metrics indicate a price-to-earnings ratio of 10.02, suggesting a balanced valuation in the context of its earnings performance. Zhejiang Medicine Co. Ltd. has been publicly traded since its initial public offering on August 11, 1999, marking over two decades of presence in the stock market.
For those interested in learning more about Zhejiang Medicine Co. Ltd. and its offerings, additional information is available on its official website at www.china-zmc.com . The company’s continued focus on innovation and expansion in the pharmaceutical sector positions it as a key player in the health care industry.